Approval · Notice of Compliance 28767 · 2022
AVONEX: Notice of Compliance 28767
Issued August 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28767
- Date
- August 15, 2022
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Mongoraph Update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVONEX | Not yet assigned | — |
Medicinal ingredients
- INTERFERON BETA-1A 30 MCG per 0.5ML